- LANATOSIDE B
-
- $0.00 / 25kg
-
2024-04-12
- CAS:17575-21-2
- Min. Order: 1kg
- Purity: 99%
- Supply Ability: 2000ton
|
| | LANATOSIDE B Basic information |
| Product Name: | LANATOSIDE B | | Synonyms: | LANATOSIDE B;20(22),5BETA-CARDENOLID-3BETA,14BETA,16BETA-TRIOL 3BETA-[O-BETA-D-GALACTOPYRANOSYL-(1->4)-O-BETA-D-[3-O-ACETYLDIGITOXOPYRANOSYL]-(1->4)-DIGITOXOPYRANOSYL-(1->4)-O-BETA-D-DIGITOXOPYRANOSIDE];digilanidb;digilanideb;LANTOSIDEB;Card-20(22)-enolide, 3-[(O-β-D-glucopyranosyl-(1→4)-O-3-O-acetyl-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-O-2,6-dideoxy-β-D-ribo-hexopyranosyl-(1→4)-2,6-dideoxy-β-D-ribo-hexopyranosyl)oxy]-14,16-dihydroxy-, (3β,5β,16β)- | | CAS: | 17575-21-2 | | MF: | C49H76O20 | | MW: | 985.12 | | EINECS: | 241-545-6 | | Product Categories: | Cardioglycosides & Glycosides | | Mol File: | 17575-21-2.mol |  |
| | LANATOSIDE B Chemical Properties |
| Melting point | 245-248°C | | alpha | D20 +36.7° (0.47 g in 25 ml 95% alc); D20 +31.8° (0.25 g in 14.1 ml dioxane) | | Boiling point | 741.7°C (rough estimate) | | density | 1.1256 (rough estimate) | | refractive index | 1.7630 (estimate) | | pKa | 12.89±0.70(Predicted) | | LogP | -0.250 (est) |
| | LANATOSIDE B Usage And Synthesis |
| Uses | Lanatoside B is a novel cardiac glycoside inhibitor acting on sodium-potassium ATPase in vivo. | | Purification Methods | Crystallise lanatoside B from MeOH. Its solubility is: 1/20 (MeOH), 1/40 (EtOH), 1/5600 (CHCl3), and is insoluble in H2O. [Stoll et al. Helv Chim Acta 16 1049 1933, Miyatake et al. Chem Pharm Bull Jpn 5 171 1957, Beilstein 18 III/IV 2465.] It is cardiotonic. |
| | LANATOSIDE B Preparation Products And Raw materials |
|